Insights

Innovative Analytical Solutions Cygnus Technologies' development of proprietary assays such as the C1 HCP ELISA and MockV RVLP Kit highlights a strong focus on advanced impurity detection. This creates opportunities to cross-sell or upsell tailored bioprocess analytics tools to biopharmaceutical companies seeking to improve product safety and accelerate regulatory approval.

Recent Industry Recognition Receiving the 2023 R&D 100 Award underscores Cygnus's reputation for innovation and excellence in analytical testing. This recognition can be leveraged in marketing efforts to attract new clients interested in top-tier technology solutions for bioprocess validation and impurity analysis.

Strategic Partnerships Cygnus's collaborations with organizations like Gyros Protein Technologies and Bio-Techne demonstrate a strategic approach to expanding product capabilities and market reach. Business development efforts can target similar partnerships with biotech service providers and reagent suppliers to broaden the distribution network.

Market Expansion Potential The company's focus on host cell protein detection, viral clearance, and impurity analytics addresses critical needs across vaccine, gene therapy, and monoclonal antibody markets. These sectors present substantial sales opportunities as biopharmaceutical manufacturers seek reliable, innovative solutions to meet stringent regulatory standards.

Growing Financial Profile With revenue between $25 million and $50 million and a strong industry reputation, Cygnus is positioned for growth. Sales teams can approach medium-sized biotechs and contract manufacturing organizations expanding their bioprocessing capacities with value-driven impurity detection technologies.

Cygnus Technologies, LLC Tech Stack

Cygnus Technologies, LLC uses 8 technology products and services including Lucidchart, Amazon S3, OneTrust, and more. Explore Cygnus Technologies, LLC's tech stack below.

  • Lucidchart
    Charting
  • Amazon S3
    Content Delivery Network
  • OneTrust
    Cookie Compliance
  • Cart Functionality
    E-commerce
  • parallax.js
    Javascript Libraries
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • FedEx
    Transportation And Fleet Management
  • Magnific Popup
    Web Tools And Plugins

Media & News

Cygnus Technologies, LLC's Email Address Formats

Cygnus Technologies, LLC uses at least 1 format(s):
Cygnus Technologies, LLC Email FormatsExamplePercentage
First@cygnustechnologies.comJohn@cygnustechnologies.com
52%
First.Last@cygnustechnologies.comJohn.Doe@cygnustechnologies.com
20%
FirstL@cygnustechnologies.comJohnD@cygnustechnologies.com
14%
FLast@cygnustechnologies.comJDoe@cygnustechnologies.com
14%

Frequently Asked Questions

Where is Cygnus Technologies, LLC's headquarters located?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC's main headquarters is located at 1523 Olde Waterford Way Leland, North Carolina 28451 United States. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Cygnus Technologies, LLC's official website and social media links?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC's official website is cygnustechnologies.com and has social profiles on LinkedIn.

What is Cygnus Technologies, LLC's SIC code NAICS code?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cygnus Technologies, LLC have currently?

Minus sign iconPlus sign icon
As of May 2026, Cygnus Technologies, LLC has approximately 77 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Executive Officer: V. M.Coo: C. D.Chief Revenue Officer: D. C.. Explore Cygnus Technologies, LLC's employee directory with LeadIQ.

What industry does Cygnus Technologies, LLC belong to?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC operates in the Biotechnology Research industry.

What technology does Cygnus Technologies, LLC use?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC's tech stack includes LucidchartAmazon S3OneTrustCart Functionalityparallax.jsSalesforce Marketing Cloud Account EngagementFedExMagnific Popup.

What is Cygnus Technologies, LLC's email format?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC's email format typically follows the pattern of First@cygnustechnologies.com. Find more Cygnus Technologies, LLC email formats with LeadIQ.

When was Cygnus Technologies, LLC founded?

Minus sign iconPlus sign icon
Cygnus Technologies, LLC was founded in 1997.

Cygnus Technologies, LLC

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Cygnus Technologies, part of Maravai LifeSciences, provides best-in-class analytical tools and solutions to help companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. As the biopharmaceutical industry’s partner in analytics for host cell proteins (HCP), other process-related impurities, and viral clearance, Cygnus’ off-the-shelf products and custom services ultimately improve bioprocess development for faster regulatory approval and better clinical outcomes. 
Founded by Ken Hoffman in 1997, Cygnus is an industry pioneer responsible for developing and commercializing the first generic assay kits for HCP detection. Its reputation for quality is recognized by the industry and global regulatory agencies; as of April 1, 2026, Cygnus’ off-the shelf and custom assays have been used for lot release testing of multiple licensed novel biologics, biosimilars, vaccines and 28 FDA- and EMA-approved cell and gene therapies. Cygnus continues to advance the science of bioprocess impurity detection with new breakthroughs, including its Antibody Affinity Extraction™ (AAE) technology and orthogonal methods of HCP analysis that integrate Mass Spectrometry, AAE and ELISA. To reduce the cost and risk associated with viral clearance studies, Cygnus offers an innovative approach that utilizes non-infectious mock virus particles through its MockV™ virus clearance kits. 
Cygnus’ proprietary technologies, available through its products and custom assays/services, set the gold standard for enabling HCP and other bioprocess impurity antibody assays. Cygnus delivers best-in-class customer service and technical expertise, operational excellence and ISO-9001:2015 certified quality management systems. 
Located in Leland, North Carolina, Cygnus Technologies is online at www.cygnustechnologies.com.

Section iconCompany Overview

Headquarters
1523 Olde Waterford Way Leland, North Carolina 28451 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1997
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    Cygnus Technologies, LLC's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    Cygnus Technologies, LLC's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.